- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg med Influenza med lungebetændelse
I alt 18462 resultater
-
Sanofi Pasteur, a Sanofi CompanyAfsluttetInfluenzavaccinationPuerto Rico, Forenede Stater
-
National Institute of Allergy and Infectious Diseases...Afsluttet
-
AB Biotics, SAAfsluttetInfluenzavaccineSpanien
-
National Institute of Allergy and Infectious Diseases...Afsluttet
-
GlaxoSmithKlineAfsluttetInfluenza | InfluenzavaccinerSpanien
-
GlaxoSmithKlineAfsluttetInfluenza | InfluenzavaccinerTyskland
-
GlaxoSmithKlineAfsluttet
-
PharmaJet, Inc.Afsluttet
-
The University of Texas Health Science Center,...Gilstrap, Larry C, M.D.Afsluttet
-
Butantan InstituteAfsluttet
-
Novartis VaccinesAfsluttet
-
Novartis VaccinesAfsluttetInfluenzapandemiDominikanske republik, Belgien, Tyskland
-
Ology BioservicesAfsluttet
-
University of AlbertaAfsluttet
-
Kirby InstituteNational Health and Medical Research Council, AustraliaTrukket tilbage
-
Novartis VaccinesAfsluttetInfluenzapandemiHolland, Belgien, Chile, Dominikanske republik, Tyskland
-
GlaxoSmithKlineAfsluttetHepatitis B | Stivkrampe | Difteri | Acellulær Pertussis | Poliomyelitis | Haemophilus Influenzae Type b | Difteri-Stivkrampe-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria MeniPolen
-
Joint Stock Company "Farmak"AfsluttetMenneskelig influenza | Akutte luftvejsvirusinfektioner
-
Ology BioservicesAfsluttetFase 1 sikkerhedsundersøgelse af GelVac Nasal Powder H5N1 influenzavaccineForenede Stater
-
Jiangsu Simcere Pharmaceutical Co., Ltd.AfsluttetInfluenza A-virusinfektion | Influenza B-virusinfektionKina
-
Janssen Vaccines & Prevention B.V.AfsluttetInfluenza, menneskelig forebyggelse | Forebyggelse af respiratoriske syncytielle viraForenede Stater
-
Novartis VaccinesAfsluttet
-
Boston Medical CenterAfsluttetInfluenza | Influenza-Like IllnessForenede Stater
-
Novartis VaccinesAfsluttet
-
Novartis VaccinesAfsluttetSeasonal Influenza, VaccineTyskland
-
LG Life SciencesUkendtHepatitis B | Pertussis | Stivkrampe | Difteri | Haemophilus Influenza Type B
-
Sanofi Pasteur, a Sanofi CompanyAfsluttetInfluenzavaccinationForenede Stater, Puerto Rico
-
Imperial College LondonPublic Health EnglandAfsluttetInfluenzavaccinerDet Forenede Kongerige
-
Sanofi Pasteur, a Sanofi CompanyAfsluttetInfluenzavaccinationForenede Stater, Danmark, Polen, Spanien
-
National Institute of Allergy and Infectious Diseases...AfsluttetInfluenza | InfluenzavaccinationForenede Stater
-
National Institute of Allergy and Infectious Diseases...AfsluttetInfluenza | InfluenzavaccinationForenede Stater
-
FluGen IncNational Institute of Allergy and Infectious Diseases (NIAID)AfsluttetInfluenzavaccineForenede Stater
-
FluGen IncUnited States Department of DefenseAfsluttetInfluenzavaccineForenede Stater
-
National Institute of Allergy and Infectious Diseases...Afsluttet
-
MedImmune LLCAfsluttet
-
National Institute of Allergy and Infectious Diseases...Afsluttet
-
National Institute of Allergy and Infectious Diseases...AfsluttetInfluenza | InfluenzavaccinationForenede Stater
-
GlaxoSmithKlineAfsluttetInfluenza | InfluenzavaccinerTaiwan, Hong Kong, Thailand, Singapore
-
University of WarwickUniversity Hospital BirminghamAfsluttetInfluenzavaccinationDet Forenede Kongerige
-
Adimmune CorporationAfsluttetInfluenzapandemiTaiwan
-
Ology BioservicesAfsluttetInfluenza | InfluenzapandemiForenede Stater
-
Ology BioservicesAfsluttetInfluenza | InfluenzapandemiØstrig, Tyskland
-
University of British ColumbiaPHAC/CIHR Influenza Research NetworkAfsluttet
-
Columbia UniversityAfsluttet
-
NovavaxAfsluttet
-
Kirby InstituteNational Health and Medical Research Council, AustraliaTrukket tilbage
-
Kirby InstituteNational Health and Medical Research Council, AustraliaTrukket tilbage
-
Abbott BiologicalsQuintiles, Inc.AfsluttetInfluenzavaccinerTjekkiet, Estland, Litauen
-
University of British ColumbiaGlaxoSmithKline; Canadian Institutes of Health Research (CIHR)AfsluttetHIV-infektioner | H1N1 influenzaCanada
-
National Institute of Allergy and Infectious Diseases...AfsluttetBestem minimal til moderat infektionsdosis (MMID) af influenza A H3N2Forenede Stater